In the article "Stockes to rise! Biopharmaceutical Stocks" in the Weekly Economist (Nov. 8, 2022) featured by The Weekly Economist (November 8, 2022 issue), PtBio Inc. was featured as one of the "5 Biotech Ventures Not Listed in Japan to Check Out Now!
The article introduces an initiative with Vision Care Inc. (President: Masayo TAKAHASHI), which aims at genome therapy for ocular diseases, as an example of medical applications.
PtBio Inc. is committed to provide proprietary genome editing technologies that can be used in the medical field and work with business partners to build drug discovery pipelines.
<Reference Links>
